Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

The role of exercise in improving patient-reported outcomes in individuals on dialysis: A scoping review.

Bohm C, Schick-Makaroff K, MacRae JM, Tan M, Thompson S.

Semin Dial. 2019 Apr 21. doi: 10.1111/sdi.12806. [Epub ahead of print]

PMID:
31006928
2.

Anticoagulation in CKD and ESRD.

Leung KC, MacRae JM.

J Nephrol. 2019 Jan 28. doi: 10.1007/s40620-019-00592-4. [Epub ahead of print] Review.

PMID:
30689127
3.

CPAP Therapy Delays Cardiovagal Reactivation and Decreases Arterial Renin-Angiotensin System Activity in Humans With Obstructive Sleep Apnea.

Nicholl DDM, Hanly PJ, Zalucky AA, Mann MC, MacRae JM, Poulin MJ, Handley GB, Sola DY, Ahmed SB.

J Clin Sleep Med. 2018 Sep 15;14(9):1509-1520. doi: 10.5664/jcsm.7326.

4.

Vascular Access Practice Patterns in Canada: A National Survey.

Dumaine C, Kiaii M, Miller L, Moist L, Oliver MJ, Lok CE, Hiremath S, MacRae JM.

Can J Kidney Health Dis. 2018 Feb 28;5:2054358118759675. doi: 10.1177/2054358118759675. eCollection 2018.

5.

Central venous catheters for chronic hemodialysis: Is "last choice" never the "right choice"?

Dumaine CS, Brown RS, MacRae JM, Oliver MJ, Ravani P, Quinn RR.

Semin Dial. 2018 Jan;31(1):3-10. doi: 10.1111/sdi.12655. Epub 2017 Nov 2. Review.

PMID:
29098715
6.

Randomized Crossover Trial of Blood Volume Monitoring-Guided Ultrafiltration Biofeedback to Reduce Intradialytic Hypotensive Episodes with Hemodialysis.

Leung KCW, Quinn RR, Ravani P, Duff H, MacRae JM.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1831-1840. doi: 10.2215/CJN.01030117. Epub 2017 Oct 10.

7.

Impact of intradialytic exercise intensity on urea clearance in hemodialysis patients.

Brown PDS, Rowed K, Shearer J, MacRae JM, Parker K.

Appl Physiol Nutr Metab. 2018 Jan;43(1):101-104. doi: 10.1139/apnm-2017-0460. Epub 2017 Sep 29.

8.

Hemodialysis Tunneled Catheter Noninfectious Complications.

Miller LM, MacRae JM, Kiaii M, Clark E, Dipchand C, Kappel J, Lok C, Luscombe R, Moist L, Oliver M, Pike P, Hiremath S; Canadian Society of Nephrology Vascular Access Work Group.

Can J Kidney Health Dis. 2016 Sep 27;3:2054358116669130. doi: 10.1177/2054358116669130. eCollection 2016.

9.

Arteriovenous Access: Infection, Neuropathy, and Other Complications.

MacRae JM, Dipchand C, Oliver M, Moist L, Yilmaz S, Lok C, Leung K, Clark E, Hiremath S, Kappel J, Kiaii M, Luscombe R, Miller LM; Canadian Society of Nephrology Vascular Access Work Group.

Can J Kidney Health Dis. 2016 Sep 27;3:2054358116669127. doi: 10.1177/2054358116669127. eCollection 2016.

10.

Arteriovenous Access Failure, Stenosis, and Thrombosis.

MacRae JM, Dipchand C, Oliver M, Moist L, Lok C, Clark E, Hiremath S, Kappel J, Kiaii M, Luscombe R, Miller LM; Canadian Society of Nephrology Vascular Access Work Group.

Can J Kidney Health Dis. 2016 Sep 27;3:2054358116669126. doi: 10.1177/2054358116669126. eCollection 2016.

11.

Arteriovenous Vascular Access Selection and Evaluation.

MacRae JM, Oliver M, Clark E, Dipchand C, Hiremath S, Kappel J, Kiaii M, Lok C, Luscombe R, Miller LM, Moist L; Canadian Society of Nephrology Vascular Access Work Group.

Can J Kidney Health Dis. 2016 Sep 27;3:2054358116669125. doi: 10.1177/2054358116669125. eCollection 2016.

12.

Emergency Department Use among Patients with CKD: A Population-Based Analysis.

Ronksley PE, Tonelli M, Manns BJ, Weaver RG, Thomas CM, MacRae JM, Ravani P, Quinn RR, James MT, Lewanczuk R, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):304-314. doi: 10.2215/CJN.06280616. Epub 2017 Jan 24.

13.

Sex differences in associations between insulin resistance, heart rate variability, and arterial stiffness in healthy women and men: a physiology study.

Rannelli LA, MacRae JM, Mann MC, Ramesh S, Hemmelgarn BR, Rabi D, Sola DY, Ahmed SB.

Can J Physiol Pharmacol. 2017 Apr;95(4):349-355. doi: 10.1139/cjpp-2016-0122. Epub 2016 Nov 2.

PMID:
28099042
14.

A Clinical Risk Prediction Tool for 6-Month Mortality After Dialysis Initiation Among Older Adults.

Wick JP, Turin TC, Faris PD, MacRae JM, Weaver RG, Tonelli M, Manns BJ, Hemmelgarn BR.

Am J Kidney Dis. 2017 May;69(5):568-575. doi: 10.1053/j.ajkd.2016.08.035. Epub 2016 Nov 14.

PMID:
27856091
15.

The VITAH Trial-Vitamin D Supplementation and Cardiac Autonomic Tone in Patients with End-Stage Kidney Disease on Hemodialysis: A Blinded, Randomized Controlled Trial.

Mann MC, Exner DV, Hemmelgarn BR, Hanley DA, Turin TC, MacRae JM, Wheeler DC, Sola DY, Ramesh S, Ahmed SB.

Nutrients. 2016 Sep 28;8(10). pii: E608.

16.

Citrate vs. acetate dialysate on intradialytic heparin dose: A double blind randomized crossover study.

Leung KC, Tai DJ, Ravani P, Quinn RR, Scott-Douglas N, MacRae JM.

Hemodial Int. 2016 Oct;20(4):537-547. doi: 10.1111/hdi.12433. Epub 2016 Jun 20.

PMID:
27325599
17.

Preemptive Correction of Arteriovenous Access Stenosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Ravani P, Quinn RR, Oliver MJ, Karsanji DJ, James MT, MacRae JM, Palmer SC, Strippoli GF.

Am J Kidney Dis. 2016 Mar;67(3):446-60. doi: 10.1053/j.ajkd.2015.11.013. Epub 2016 Jan 6. Erratum in: Am J Kidney Dis. 2017 Nov;70(5):735.

PMID:
26776537
18.

Pre-emptive correction for haemodialysis arteriovenous access stenosis.

Ravani P, Quinn RR, Oliver MJ, Karsanji DJ, James MT, MacRae JM, Palmer SC, Strippoli GF.

Cochrane Database Syst Rev. 2016 Jan 7;(1):CD010709. doi: 10.1002/14651858.CD010709.pub2. Review.

19.

The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial.

Tai DJ, Leung K, Ravani P, Quinn RR, Scott-Douglas N, MacRae JM; Alberta Kidney Disease Network.

BMC Nephrol. 2015 Aug 25;16:147. doi: 10.1186/s12882-015-0144-z.

20.

Role of vascular function in predicting arteriovenous fistula outcomes: an observational pilot study.

MacRae JM, Ahmed S, Hemmelgarn B, Sun Y, Martin BJ, Roifman I, Anderson T.

Can J Kidney Health Dis. 2015 May 4;2:19. doi: 10.1186/s40697-015-0055-8. eCollection 2015.

21.

The care and keeping of vascular access for home hemodialysis patients.

Faratro R, Jeffries J, Nesrallah GE, MacRae JM.

Hemodial Int. 2015 Apr;19 Suppl 1:S80-92. doi: 10.1111/hdi.12242. Review.

PMID:
25925828
22.

The association between intradialytic exercise and hospital usage among hemodialysis patients.

Parker K, Zhang X, Lewin A, MacRae JM.

Appl Physiol Nutr Metab. 2015 Apr;40(4):371-8. doi: 10.1139/apnm-2014-0326.

PMID:
25819883
23.

Serum uric acid level, blood pressure, and vascular angiotensin II responsiveness in healthy men and women.

Samimi A, Ramesh S, Turin TC, MacRae JM, Sarna MA, Reimer RA, Hemmelgarn BR, Sola DY, Ahmed SB.

Physiol Rep. 2014 Dec 11;2(12). pii: e12235. doi: 10.14814/phy2.12235. Print 2014 Dec 1.

24.
25.

Conservative management of an iatrogenic arteriovenous fistula.

Miller RJ, MacRae JM, Mustata S.

Nephron Extra. 2014 Oct 3;4(3):155-8. doi: 10.1159/000366451. eCollection 2014 Sep.

26.

In Reply to 'Buttonhole cannulation: the jury is still out'.

MacRae JM.

Am J Kidney Dis. 2014 Oct;64(4):658. doi: 10.1053/j.ajkd.2014.06.028. No abstract available.

PMID:
25257328
27.

The VITAH trial VITamin D supplementation and cardiac Autonomic tone in Hemodialysis: a blinded, randomized controlled trial.

Mann MC, Exner DV, Hemmelgarn BR, Hanley DA, Turin TC, MacRae JM, Ahmed SB.

BMC Nephrol. 2014 Aug 6;15:129. doi: 10.1186/1471-2369-15-129.

28.

Progress in dialysis practice: an introduction.

MacRae JM, Copland M, Kiaii M.

Semin Dial. 2014 Mar;27(2):85-6. doi: 10.1111/sdi.12202. No abstract available.

PMID:
24588801
29.

IgA nephropathy with early kidney disease is associated with increased arterial stiffness and renin-angiotensin system activity.

Abdi-Ali A, Mann MC, Hemmelgarn BR, MacRae JM, Turin TC, Benediktsson H, Sola DY, Ahmed SB.

J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):521-8. doi: 10.1177/1470320313510586. Epub 2014 Jan 24.

PMID:
24464859
30.

Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial.

Ward DR, Moist LM, MacRae JM, Scott-Douglas N, Zhang J, Tonelli M, Lok CE, Soroka SD, Hemmelgarn BR.

Can J Kidney Health Dis. 2014 Jul 8;1:15. doi: 10.1186/2054-3581-1-15. eCollection 2014.

31.

Programmatic variation in home hemodialysis in Canada: results from a nationwide survey of practice patterns.

Pauly RP, Komenda P, Chan CT, Copland M, Gangji A, Hirsch D, Lindsay R, MacKinnon M, MacRae JM, McFarlane P, Nesrallah G, Pierratos A, Plaisance M, Reintjes F, Rioux JP, Shik J, Steele A, Stryker R, Wu G, Zimmerman DL.

Can J Kidney Health Dis. 2014 Jun 10;1:11. doi: 10.1186/2054-3581-1-11. eCollection 2014.

32.

Buttonhole cannulation technique as the cannulation method of choice.

Macrae JM, Ahmed SB, Hemmelgarn BR.

Am J Kidney Dis. 2014 Jan;63(1):165. doi: 10.1053/j.ajkd.2013.09.022. No abstract available.

PMID:
24360226
33.

Arteriovenous fistula survival and needling technique: long-term results from a randomized buttonhole trial.

Macrae JM, Ahmed SB, Hemmelgarn BR; Alberta Kidney Disease Network.

Am J Kidney Dis. 2014 Apr;63(4):636-42. doi: 10.1053/j.ajkd.2013.09.015. Epub 2013 Nov 13.

PMID:
24239019
34.

25-Hydroxyvitamin D status, arterial stiffness and the renin-angiotensin system in healthy humans.

Abdi-Ali A, Nicholl DD, Hemmelgarn BR, MacRae JM, Sola DY, Ahmed SB.

Clin Exp Hypertens. 2014;36(6):386-91. doi: 10.3109/10641963.2013.827705. Epub 2013 Oct 28.

PMID:
24164282
35.

The buttonhole technique for fistula cannulation: pros and cons.

Atkar RK, MacRae JM.

Curr Opin Nephrol Hypertens. 2013 Nov;22(6):629-36. doi: 10.1097/MNH.0b013e328365ae9e. Review.

PMID:
24076555
36.

Sex influences the effect of body mass index on the vascular response to angiotensin II in humans.

Zalucky AA, Nicholl DD, Mann MC, Hemmelgarn BR, Turin TC, Macrae JM, Sola DY, Ahmed SB.

Obesity (Silver Spring). 2014 Mar;22(3):739-46. doi: 10.1002/oby.20608. Epub 2013 Sep 20.

37.

Associations between hemodialysis access type and clinical outcomes: a systematic review.

Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, Pannu NI, Thomas C, Hemmelgarn BR, Craig JC, Manns B, Tonelli M, Strippoli GF, James MT.

J Am Soc Nephrol. 2013 Feb;24(3):465-73. doi: 10.1681/ASN.2012070643. Epub 2013 Feb 21. Review.

38.

Pneumatic compression devices during hemodialysis: a randomized crossover trial.

Tai DJ, Ahmed SB, Palacios-Derflingher L, Hemmelgarn BR, MacRae JM; Alberta Kidney Disease Network.

Nephrol Dial Transplant. 2013 Apr;28(4):982-90. doi: 10.1093/ndt/gfs502. Epub 2012 Nov 7.

PMID:
23136215
39.

A randomized trial comparing buttonhole with rope ladder needling in conventional hemodialysis patients.

MacRae JM, Ahmed SB, Atkar R, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1632-8. doi: 10.2215/CJN.02730312. Epub 2012 Jul 19.

40.

Hemodialysis prescription education decreases intradialytic hypotension.

Tai DJ, Conley J, Ravani P, Hemmelgarn BR, MacRae JM.

J Nephrol. 2013 Mar-Apr;26(2):315-22. doi: 10.5301/jn.5000147. Epub 2012 Jun 11.

PMID:
22711438
41.

Increased urinary protein excretion in the "normal" range is associated with increased renin-angiotensin system activity.

Nicholl DD, Hemmelgarn BR, Turin TC, MacRae JM, Muruve DA, Sola DY, Ahmed SB.

Am J Physiol Renal Physiol. 2012 Mar 1;302(5):F526-32. doi: 10.1152/ajprenal.00458.2011. Epub 2011 Nov 16.

42.

Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients.

Thomson BK, MacRae JM, Barnieh L, Zhang J, MacKay E, Manning MA, Hemmelgarn BR.

BMC Nephrol. 2011 Sep 26;12:46. doi: 10.1186/1471-2369-12-46.

43.

Suboptimal initiation of dialysis with and without early referral to a nephrologist.

Mendelssohn DC, Curtis B, Yeates K, Langlois S, MacRae JM, Semeniuk LM, Camacho F, McFarlane P; STARRT Study investigators.

Nephrol Dial Transplant. 2011 Sep;26(9):2959-65. doi: 10.1093/ndt/gfq843. Epub 2011 Jan 31.

PMID:
21282303
44.

Morphometric and biological characterization of biofilm in tunneled hemodialysis catheters.

Jones SM, Ravani P, Hemmelgarn BR, Muruve D, Macrae JM.

Am J Kidney Dis. 2011 Mar;57(3):449-55. doi: 10.1053/j.ajkd.2010.10.053. Epub 2011 Jan 22.

PMID:
21257245
45.

Utilization and outcome of 'out-of-center hemodialysis' in the United States: a contemporary analysis.

MacRae JM, Rose CL, Jaber BL, Gill JS.

Nephron Clin Pract. 2010;116(1):c53-9. doi: 10.1159/000314663. Epub 2010 May 21.

46.

A simple method to create buttonhole cannulation tracks in a busy hemodialysis unit.

Macrae JM, Tai DJ, Daniw M, Lee J.

Hemodial Int. 2010 Jan;14(1):94-5. doi: 10.1111/j.1542-4758.2009.00428.x. No abstract available.

PMID:
20377653
47.

Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality.

Boudville NC, Djurdjev O, Macdougall IC, de Francisco AL, Deray G, Besarab A, Stevens PE, Walker RG, Ureña P, Iñigo P, Minutolo R, Haviv YS, Yeates K, Agüera ML, MacRae JM, Levin A.

Clin J Am Soc Nephrol. 2009 Jul;4(7):1176-82. doi: 10.2215/CJN.04920908. Epub 2009 May 7.

48.
49.

Oral estrogen therapy in postmenopausal women is associated with loss of kidney function.

Ahmed SB, Culleton BF, Tonelli M, Klarenbach SW, Macrae JM, Zhang J, Hemmelgarn BR; Alberta Kidney Disease Network.

Kidney Int. 2008 Aug;74(3):370-6. doi: 10.1038/ki.2008.205. Epub 2008 May 21.

50.

Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).

Macrae JM, Dojcinovic I, Djurdjev O, Jung B, Shalansky S, Levin A, Kiaii M.

Clin J Am Soc Nephrol. 2008 Mar;3(2):369-74. doi: 10.2215/CJN.01760407.

Supplemental Content

Loading ...
Support Center